Jason Duncan

Jason Duncan joined Neumora in 2023 and is currently Chief Legal and Administrative Officer, bringing more than two decades of legal, compliance, development and operations experience in the life sciences industry. Prior to joining Neumora, Mr. Duncan served as Chief Legal Officer, General Counsel, Secretary to the Board of Directors and Head of Program Management at Albireo Pharma, a publicly traded Boston-based biotech company that was acquired by Ipsen. During his time at Albireo, Mr. Duncan contributed to growing the company from an early clinical stage biotech to a fully integrated commercial organization with two drug approvals and a global launch. Prior to Albireo, Mr. Duncan served as General Counsel, Americas at Stallergenes Greer Holdings and Vice President, Head of Compliance and Legal, North America at Sobi, Inc. Earlier in his career Mr. Duncan held roles at EMD Serono, Inc., Acushnet Company, Nixon Peabody LLP and Peabody & Arnold LLP. Mr. Duncan holds a J.D., magna cum laude, from Suffolk University Law School and a B.A. in Political Science from Dickinson College.